NIH: Thanks for the funds; FDA: Where's ours?
This article was originally published in Scrip
Executive Summary
Lawmakers acknowledged at a 30 April Capitol Hill hearing that much more work needs to be done on a revised bill aimed at overhauling the US biomedical research enterprise and the process for assessing and approving new therapies – the 21st Century Cures Act – which was unveiled a day earlier.